EBM — Eastwood Bio-Medical Canada Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$53.04m
- CA$53.08m
- CA$0.87m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.577 | -0.852 | -0.604 | -0.15 | -0.547 |
Depreciation | |||||
Non-Cash Items | 0.097 | 0.02 | -0.012 | 0.005 | 0.004 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.256 | 0.184 | 0.394 | 0.034 | 0.418 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.178 | -0.543 | -0.116 | -0.004 | -0.017 |
Capital Expenditures | -0.023 | 0 | -0.006 | -0.003 | — |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.023 | 0 | -0.006 | -0.003 | — |
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0.04 | 0.02 | 0.026 | -0.004 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.201 | -0.503 | -0.102 | 0.019 | -0.021 |